Advertisement

Extrakorporale Nierenersatztherapie bei akuter Nierenschädigung

Empfehlungen der Sektionen „Niere“ der DGIIN, ÖGIAIN und DIVI
  • V. Schwenger
  • D. Kindgen-Milles
  • C. Willam
  • A. Jörres
  • W. Druml
  • D. Czock
  • S. J. Klein
  • M. Oppert
  • M. Schmitz
  • J. T. Kielstein
  • A. Zarbock
  • M. Joannidis
  • S. John
Leitlinien und Empfehlungen

Zusammenfassung

Hintergrund

Eine akute Nierenschädigung ist bei Intensivpatienten mit bis zu über 50 % eine häufige Komplikation, die mit hoher Morbidität, Mortalität und schlechter Langzeitprognose assoziiert ist. Bei 5–25 % dieser Patienten mit akuter Nierenschädigung auf der Intensivstation ist eine Nierenersatztherapie notwendig. Es stehen hierfür unterschiedliche Nierenersatzverfahren zur Verfügung.

Ziel der Arbeit

Um Indikation, Zeitpunkt, Auswahl und Anwendung der Nierenersatztherapie beim Erwachsenen zu erleichtern, werden aktuelle Empfehlungen der Sektionen Niere der Deutschen Gesellschaft für Internistische Intensivmedizin und Notfallmedizin (DGIIN), der Österreichischen Gesellschaft für Internistische und Allgemeine Intensivmedizin und Notfallmedizin (ÖGIAIN) und der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI) dargestellt.

Material und Methoden

Die Empfehlungen dieser Arbeit basieren auf den aktuellen KDIGO(Kidney Disease: Improving Global Outcomes)-Leitlinien, den Empfehlungen der 17th Acute Disease Quality Initiative (ADQI)/Consensus Group der Französischen Intensivmedizinischen Fachgesellschaften (SRLF, SFAR) und der Expertenmeinung und klinischer Erfahrung der Autoren.

Ergebnisse

Kontinuierliche Verfahren unterscheiden sich hinsichtlich der Mortalität nicht von intermittierenden oder verlängerten Dialyseverfahren, weisen aber Unterschiede in der Handhabung und Ökonomie auf. Eine individualisierte Risikostratifizierung bezüglich des Behandlungsbeginns und der Verfahrenswahl sollte erfolgen.

Schlüsselwörter

Akutes Nierenversagen Dialyse Hämodialyse Hämofiltration AKI 

Extracorporeal renal replacement therapy in acute kidney injury

Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI

Abstract

Background

Acute kidney injury (AKI) is a common complication in intensive care unit (ICU) patients. The incidence of AKI in ICU patients exceeds 50% and the associated morbidity and mortality rates increase with severity of AKI. In addition, long-term consequences of AKI are underestimated and several studies show impaired long-term outcome after AKI. In about 5–25% of ICU patients with AKI renal replacement therapy (RRT) is required.

Objectives

To assist in indication, timing, modality and application of renal replacement therapy of adult patients, current recommendations from the renal sections of the DGIIN (Deutschen Gesellschaft für Internistische Intensivmedizin und Notfallmedizin), ÖGIAIN (Österreichischen Gesellschaft für Internistische und Allgemeine Intensivmedizin und Notfallmedizin) and DIVI (Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin) are stated.

Materials and methods

The recommendations stated in this paper are based on the current KDIGO (Kidney Disease: Improving Global Outcomes) guidelines, recommendations from the 17th Acute Disease Quality Initiative (ADQI) Consensus Group, the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) and the expert knowledge and clinical experience of the authors.

Results

Today, different treatment modalities for RRT are available. Although continuous RRT and intermittent dialysis therapy as well as continuous dialysis therapy have comparable outcomes, differences exist with respect to practical application as well as health–economic aspects. Individualized risk stratification might be helpful to choose the right time to start and the right treatment modality for patients.

Keywords

Acute kidney injury Dialysis Hemodialysis Hemofiltration AKI 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

D. Kindgen-Milles, C. Willam, A. Jörres, W. Druml, D. Czock, S.J. Klein, M. Oppert und M. Schmitz geben an, dass kein Interessenkonflikt besteht. V. Schwenger erhielt Vortragshonorare von den Firmen Fresenius Medical Care und Baxter. J. T. Kielstein erhielt Vortragshonorare von den Firmen Fresenius Medical Care, Baxter und Terumo BCT sowie Forschungsunterstützung durch die Firma ExThera Medical. A. Zarbock erhielt finanzielle Unterstützung von den Firmen Astute Medical und Fresenius. M. Joannidis erhielt Vortrags‑/Beraterhonorare von den Firmen Baxter Healthcare Corp, CSL Behring, Fresenius, Astute Medical sowie Forschungsunterstützung von der Firma Fresenius. S. John erhielt Studienunterstützung und Vortragshonorare von der Firma Baxter.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honore PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational aki-epi study. Intensive Care Med 41:1411–1423CrossRefPubMedGoogle Scholar
  2. 2.
    Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C (2005) Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 294:813–818CrossRefPubMedGoogle Scholar
  3. 3.
    Cruz DN, Ronco C (2007) Acute kidney injury in the intensive care unit: Current trends in incidence and outcome. Crit Care 11:149CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, Jaber BL (2013) World incidence of aki: a meta-analysis. Clin J Am Soc Nephrol 8:1482–1493CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Lafrance JP, Miller DR (2010) Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol 21:345–352CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Stads S, Fortrie G, van Bommel J, Zietse R, Betjes MG (2013) Impaired kidney function at hospital discharge and long-term renal and overall survival in patients who received crrt. Clin J Am Soc Nephrol 8:1284–1291CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Coca SG, Singanamala S, Parikh CR (2012) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81:442–448CrossRefPubMedGoogle Scholar
  8. 8.
    The extracorporeal treatments in poisoning workgroup. http://www.extrip-workgroup.org/. Zugegriffen: 05.03.2018
  9. 9.
    Wald R, Adhikari NK, Smith OM, Weir MA, Pope K, Cohen A, Thorpe K, McIntyre L, Lamontagne F, Soth M, Herridge M, Lapinsky S, Clark E, Garg AX, Hiremath S, Klein D, Mazer CD, Richardson RM, Wilcox ME, Friedrich JO, Burns KE, Bagshaw SM, Canadian Critical Care Trials G (2015) Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int 88:897–904CrossRefPubMedGoogle Scholar
  10. 10.
    Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, de Prost N, Lautrette A, Bretagnol A, Mayaux J, Nseir S, Megarbane B, Thirion M, Forel JM, Maizel J, Yonis H, Markowicz P, Thiery G, Tubach F, Ricard JD, Dreyfuss D, Group AS (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:122–133CrossRefPubMedGoogle Scholar
  11. 11.
    Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, Boanta A, Gerss J, Meersch M (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the elain randomized clinical trial. JAMA 315:2190–2199CrossRefPubMedGoogle Scholar
  12. 12.
    Ostermann M, Joannidis M, Pani A, Floris M, De Rosa S, Kellum JA, Ronco C, Acute Disease Quality Initiative Consensus G (2016) Patient selection and timing of continuous renal replacement therapy. Blood Purif 42:224–237CrossRefPubMedGoogle Scholar
  13. 13.
    Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Straaten HO, Ronco C, Kellum JA (2009) Discontinuation of continuous renal replacement therapy: A post hoc analysis of a prospective multicenter observational study. Crit Care Med 37:2576–2582CrossRefPubMedGoogle Scholar
  14. 14.
    Aniort J, Ait Hssain A, Pereira B, Coupez E, Pioche PA, Leroy C, Heng AE, Souweine B, Lautrette A (2016) Daily urinary urea excretion to guide intermittent hemodialysis weaning in critically ill patients. Crit Care 20:43CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Patel SS, Holley JL (2008) Withholding and withdrawing dialysis in the intensive care unit: benefits derived from consulting the renal physicians association/american society of nephrology clinical practice guideline, shared decision-making in the appropriate initiation of and withdrawal from dialysis. Clin J Am Soc Nephrol 3:587–593CrossRefPubMedGoogle Scholar
  16. 16.
    Rabindranath K, Adams J, Macleod AM, Muirhead N (2007) Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD003773.pub3 CrossRefPubMedGoogle Scholar
  17. 17.
    Schneider AG, Bellomo R, Bagshaw SM, Glassford NJ, Lo S, Jun M, Cass A, Gallagher M (2013) Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 39:987–997CrossRefPubMedGoogle Scholar
  18. 18.
    Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, Pallot JL, Chiche JD, Taupin P, Landais P, Dhainaut JF (2006) Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 368:379–385CrossRefPubMedGoogle Scholar
  19. 19.
    Schwenger V, Weigand MA, Hoffmann O, Dikow R, Kihm LP, Seckinger J, Miftari N, Schaier M, Hofer S, Haar C, Nawroth PP, Zeier M, Martin E, Morath C (2012) Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury—a randomized interventional trial: the renal replacement therapy study in intensive care unit patients. Crit Care 16:R140CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, Fliser D (2004) Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 43:342–349CrossRefPubMedGoogle Scholar
  21. 21.
    Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK (2001) Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 60:777–785CrossRefPubMedGoogle Scholar
  22. 22.
    Friedrich JO, Wald R, Bagshaw SM, Burns KE, Adhikari NK (2012) Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care 16:R146CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Schefold JC, von Haehling S, Pschowski R, Bender T, Berkmann C, Briegel S, Hasper D, Jorres A (2014) The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (convint): a prospective randomized controlled trial. Crit Care 18:R11CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Hoste EA, De Corte W (2013) Implementing the kidney disease: improving global outcomes/acute kidney injury guidelines in icu patients. Curr Opin Crit Care 19:544–553PubMedGoogle Scholar
  25. 25.
    Vinsonneau C, Allain-Launay E, Blayau C, Darmon M, Ducheyron D, Gaillot T, Honore PM, Javouhey E, Krummel T, Lahoche A, Letacon S, Legrand M, Monchi M, Ridel C, Robert R, Schortgen F, Souweine B, Vaillant P, Velly L, Osman D, Van Vong L (2015) Renal replacement therapy in adult and pediatric intensive care : recommendations by an expert panel from the french intensive care society (srlf) with the french society of anesthesia intensive care (sfar) french group for pediatric intensive care emergencies (gfrup) the french dialysis society (sfd). Ann Intensive Care 5:58CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Bagshaw SM, Chakravarthi MR, Ricci Z, Tolwani A, Neri M, De Rosa S, Kellum JA, Ronco C, Group AC (2016) Precision continuous renal replacement therapy and solute control. Blood Purif 42:238–247CrossRefPubMedGoogle Scholar
  27. 27.
    Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638CrossRefPubMedGoogle Scholar
  28. 28.
    Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20CrossRefPubMedGoogle Scholar
  29. 29.
    Brochard L, Abroug F, Brenner M, Broccard AF, Danner RL, Ferrer M, Laghi F, Magder S, Papazian L, Pelosi P, Polderman KH (2010) An official ats/ers/esicm/sccm/srlf statement: prevention and management of acute renal failure in the icu patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med 181:1128–1155CrossRefPubMedGoogle Scholar
  30. 30.
    Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ (2011) Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 26:3508–3514CrossRefPubMedGoogle Scholar
  31. 31.
    Joannes-Boyau O, Honore PM, Perez P, Bagshaw SM, Grand H, Canivet JL, Dewitte A, Flamens C, Pujol W, Grandoulier AS, Fleureau C, Jacobs R, Broux C, Floch H, Branchard O, Franck S, Roze H, Collin V, Boer W, Calderon J, Gauche B, Spapen HD, Janvier G, Ouattara A (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (ivoire study): a multicentre randomized controlled trial. Intensive Care Med 39:1535–1546CrossRefPubMedGoogle Scholar
  32. 32.
    Wang Y, Gallagher M, Li Q, Lo S, Cass A, Finfer S, Myburgh J, Bouman C, Faulhaber-Walter R, Kellum JA, Palevsky PM, Ronco C, Saudan P, Tolwani A, Bellomo R (2017) Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: A systematic review and individual patient data meta-analysis. Nephrol Dial Transplant.  https://doi.org/10.1093/ndt/gfx308 CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA (2007) Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (b.E.S.T. Kidney) investigators. Intensive Care Med 33:1563–1570CrossRefPubMedGoogle Scholar
  34. 34.
    Anderson A, Kolff WJ (1959) Artificial kidney in the treatment of uremia associated with acute glomerulonephritis (with a note on regional heparinization). Ann Intern Med 51:476–487CrossRefPubMedGoogle Scholar
  35. 35.
    Gattas DJ, Rajbhandari D, Bradford C, Buhr H, Lo S, Bellomo R (2015) A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults. Crit Care Med 43:1622–1629CrossRefPubMedGoogle Scholar
  36. 36.
    Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer HH, Peters H, Slowinski T (2014) Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care 29:265–271CrossRefPubMedGoogle Scholar
  37. 37.
    Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC (2011) Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 26:232–239CrossRefPubMedGoogle Scholar
  38. 38.
    Liu C, Mao Z, Kang H, Hu J, Zhou F (2016) Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Crit Care 20:144CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    KDIGO (2012) Kidney disease: Improving global outcomes (kdigo) acute kidney injury work group. Kdigo clinical practice guideline for acute kidney injury. Kidney Int 2(Suppl):1–138Google Scholar
  40. 40.
    Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E (2009) Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 37:803–810CrossRefPubMedGoogle Scholar
  41. 41.
    Lehner GF, Wiedermann CJ, Joannidis M (2014) High-volume hemofiltration in critically ill patients: a systematic review and meta-analysis. Minerva Anestesiol 80:595–609PubMedGoogle Scholar
  42. 42.
    Maynar-Moliner J, Sanchez-Izquierdo-Riera JA, Herrera-Gutierrez M (2008) Renal support in critically ill patients with acute kidney injury. N Engl J Med 359:1960 (author reply 1961–1962)PubMedGoogle Scholar
  43. 43.
    Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, Liu KD, Mehta RL, Pannu N, Van Biesen W, Vanholder R (2013) Acute kidney injury: an increasing global concern. Lancet 382:170–179CrossRefPubMedGoogle Scholar
  44. 44.
    Li PK, Burdmann EA, Mehta RL (2013) Acute kidney injury: global health alert. Kidney Int 83:372–376CrossRefPubMedGoogle Scholar
  45. 45.
    (2009) Adding insult to injury. A review of the care of patients who died in hospital with aprimary diagnosis of acute kidney injury. A report by the national confidential enquiry into patient outcome and deathGoogle Scholar
  46. 46.
    Klarenbach S, Manns B, Pannu N, Clement FM, Wiebe N, Tonelli M (2009) Economic evaluation of continuous renal replacement therapy in acute renal failure. Int J Technol Assess Health Care 25:331–338CrossRefPubMedGoogle Scholar
  47. 47.
    Lewington A, Hall P (2014) The cost of ignoring acute kidney injury. Nephrol Dial Transplant 29:1270–1272CrossRefPubMedGoogle Scholar
  48. 48.
    Desai AA, Baras J, Berk BB, Nakajima A, Garber AM, Owens D, Chertow GM (2008) Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis. Arch Intern Med 168:1761–1767CrossRefPubMedGoogle Scholar
  49. 49.
    Berbece AN, Richardson RM (2006) Sustained low-efficiency dialysis in the icu: cost, anticoagulation, and solute removal. Kidney Int 70:963–968CrossRefPubMedGoogle Scholar
  50. 50.
    Nusshag C, Obermann K, Weigand M, Schwenger V (2017) Acute kidney injury—potentials to improve aki-related health care structure. Dtsch Med Wochenschr 142:534–540CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  • V. Schwenger
    • 1
  • D. Kindgen-Milles
    • 2
  • C. Willam
    • 3
  • A. Jörres
    • 4
  • W. Druml
    • 5
  • D. Czock
    • 6
  • S. J. Klein
    • 7
  • M. Oppert
    • 8
  • M. Schmitz
    • 9
  • J. T. Kielstein
    • 10
  • A. Zarbock
    • 11
  • M. Joannidis
    • 7
  • S. John
    • 12
  1. 1.Klinik für Nieren‑, Hochdruck- und AutoimmunerkrankungenKatharinenhospital, Klinikum StuttgartStuttgartDeutschland
  2. 2.Klinik für AnästhesiologieUniversitätsklinikum DüsseldorfDüsseldorfDeutschland
  3. 3.Klinik für Nephrologie und HypertensiologieUniversität Erlangen-NürnbergErlangenDeutschland
  4. 4.Medizinische Klinik I für Nephrologie, Transplantationsmedizin und internistische IntensivmedizinKlinikum der Universität Witten/HerdeckeKöln-MerheimDeutschland
  5. 5.Department für Innere Medizin IIIAllgemeines Krankenhaus WienWienÖsterreich
  6. 6.Medizinische Klinik, Abteilung Klinische Pharmakologie und PharmakoepidemiologieUniversitätsklinikum HeidelbergHeidelbergDeutschland
  7. 7.Gemeinsame Einrichtung internistische Intensiv- und Notfallmedizin, Department für Innere MedizinMedizinische Universität InnsbruckInnsbruckÖsterreich
  8. 8.Klinik für Notfall- und internistische IntensivmedizinKlinikum Ernst von BergmannPotsdamDeutschland
  9. 9.Klinik für Nephrologie und Allgemeine Innere MedizinStädtisches Klinikum SolingenSolingenDeutschland
  10. 10.Medizinische Klinik V, Nephrologie, Rheumatologie, BlutreinigungsverfahrenStädtisches Klinikum BraunschweigBraunschweigDeutschland
  11. 11.Klinik für Anästhesiologie, operative Intensivmedizin und SchmerztherapieUniversitätsklinikum MünsterMünsterDeutschland
  12. 12.Abteilung Internistische Intensivmedizin, Paracelsus Medizinischen Privatuniversität Nürnberg, Klinikum Nürnberg-SüdUniversität Erlangen-NürnbergNürnbergDeutschland

Personalised recommendations